Almirall company profile

ALM · BME · EUR

Compare Almirall
€10.50Change from previous close: −1.32%Absolute change: −€0.14

Close · November 17, 2026

Company profile

Almirall has 2,108 employees and is headquartered in Barcelona, Spain.

Operating from Barcelona since 1943, Almirall develops and sells products focused on skin health, with its main therapeutic emphasis on skin diseases such as psoriasis, atopic dermatitis, acne and actinic keratosis. Its portfolio also covers cardiovascular, respiratory and nervous system medicines. Sales reach Spain, the rest of Europe, the Middle East, the United States, Asia and Africa. The pipeline includes candidates for psoriatic arthritis and pediatric atopic dermatitis, along with earlier-stage programs in hidradenitis suppurativa and alopecia areata. Collaborations are in place with Evotec, Ichnos, Simcere, Etherna, Novo Nordisk and Eloxx. The company adopted its current name in May 2009, having previously been known as Laboratorios Almirall.

In the fiscal year ended December 2025, revenue reached EUR 1.1 billion, up 12.5% from the prior year, and net income stood at EUR 46.2 million. The company has 2,108 employees and its headquarters are in Barcelona, Spain.

Company facts

Industry
Drug Manufacturers - Specialty & Generic
Country
Spain
Headquarters
Ronda General Mitre, 151, 08022, Barcelona
Employees
2,108
Chief executive
Carlos Gallardo Piqué
Founded
1943
Fiscal year
January - December
Listing
ALM · BME
Currency
EUR
ISIN
ES0157097017

Almirall and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
AlmirallALMSpain$2.53B2,1089.6%32.1
FagronFAGRBelgium$1.9B4,88014.3%18.8
Siegfried HoldingSFZNSwitzerland$3.53B4,45416.7%17.3
Faes FarmaFAESpain$1.73B2,67713.0%18.7
Laboratorios Farmaceuticos RoviROVISpain$3.93B1,95020.2%17.4
PharmaNutraPHNItaly$875.44M12821.7%35.0

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Almirall with its competitors